Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Hyperkalemia-Induced ECG and ECHO Findings on Early and Late Mortality in Patients With Chronic Kidney Disease

NCT06635590 is registered in ClinicalTrials.gov with Saglik Bilimleri Universitesi as lead sponsor.

NCT NCT06635590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06635590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Hyperkalemia-Induced ECG and ECHO Findings on Early and Late Mortality in Patients With Chronic Kidney Disease
Lead sponsor
Saglik Bilimleri Universitesi
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2024
Completion date
February 1, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease (ckd), hemodialysis, hyperkalemia